"I haven't seen any
important, consequential moves from Amazon Pharmacy so far. And they have their
failures. Amazon has done a lot of wrong moves — it's not like they always
succeed. So I don't see a meaningful threat at this point."
— Ge Bai, Ph.D., an associate professor at Johns Hopkins
University's Carey Business School and Bloomberg School of Public Health, spoke
with AIS's RADAR on Drug
Benefits about whether she sees Amazon Pharmacy as a viable
competitor to GoodRx.
Subscribers may read the RADAR on Drug Benefits article in which this quote appeared online. Learn more about subscribing to AIS Health's publications.
No comments:
Post a Comment